APOLLOHOSP8,894.00

Apollo Hospitals Enterprise Ltd.

· Pharma & Health
₹ CrorePeersFORTISMAXHEALTHMEDANTASUNPHARMACIPLADRREDDYDIVISLABTORNTPHARMMcap ₹1.28L Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)68.3963.7165.1165.11
Receivable Days (DSO)48.1650.5150.4250.42
Payable Days (DPO)352.27296.90270.29262.62
Cash Conversion Cycle (days)-235.72-182.68-154.76-147.09
Working Capital Turnover30.988.9060.2863.15
Asset Turnover1.141.061.141.14
Cash Conversion (CFO/Net Income)2.051.421.431.43
CFO/EBITDA0.800.710.760.76
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 146%.